The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).
 
Jianming Xu
No Relationships to Disclose
 
Yi Li
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Zhijun Wu
No Relationships to Disclose
 
Tongjian Cui
No Relationships to Disclose
 
Kangsheng Gu
No Relationships to Disclose
 
Min Tao
No Relationships to Disclose
 
Xiuwen Wang
No Relationships to Disclose
 
Chengxu Cui
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Juxiang Xiao
No Relationships to Disclose
 
Quanli Gao
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Hui Zhou
Employment - Innovent Biologics
 
Yan Wang
Employment - Innovent Biologics
 
Linxinyu Xu
Employment - Innovent Biologics
 
Zhuo Ma
Employment - Innovent Biologics
 
Yanqi Wang
Employment - Innovent Biologics